Get started
Harrow, Inc.Harrow, Inc.Harrow, Inc.

Harrow, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

HROW chart


Full chart

HROW upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪1.51 B‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.94 USD
Net income (FY)
‪−24.41 M‬ USD
Revenue (FY)
‪130.19 M‬ USD
Shares float
‪30.47 M‬
Beta (1Y)
3.05

Employees


Employees (FY)
315
Change (1Y)
+98 +45.16%
Revenue / Employee (1Y)
‪413.31 K‬ USD
Net income / Employee (1Y)
‪−77.50 K‬ USD

About Harrow, Inc.


Sector
Health Technology
CEO
Mark L. Baum
Headquarters
Nashville
Website
harrow.com
Founded
2006
FIGI
BBG000QXWY44
Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Pharmaceutical Compounding and Pharmaceutical Drug Development. The Pharmaceutical Compounding segment focuses on the operations of the ImprimisRx business. The company was founded by Mark L. Baum and Robert J. Kammer in January 2006 and is headquartered in Nashville, TN.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

HROW news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of HROW is 42.44 USD — it has increased by 6.90% in the past 24 hours. Watch Harrow, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Harrow, Inc. stocks are traded under the ticker HROW.
HROW stock has fallen by −15.24% compared to the previous week, the month change is a −26.11% fall, over the last year Harrow, Inc. has showed a 346.74% increase.
We've gathered analysts' opinions on Harrow, Inc. future price: according to them, HROW price has a max estimate of 73.00 USD and a min estimate of 50.40 USD. Watch HROW chart and read a more detailed Harrow, Inc. stock forecast: see what analysts think of Harrow, Inc. and suggest that you do with its stocks.
HROW reached its all-time high on Oct 6, 2009 with the price of 160.00 USD, and its all-time low was 0.50 USD and was reached on Mar 16, 2012. View more price dynamics on HROW chart.
See other stocks reaching their highest and lowest prices.
HROW stock is 7.08% volatile and has beta coefficient of 3.05. Track Harrow, Inc. stock price on the chart and check out the list of the most volatile stocks — is Harrow, Inc. there?
Today Harrow, Inc. has the market capitalization of ‪1.51 B‬, it has decreased by −23.36% over the last week.
Yes, you can track Harrow, Inc. financials in yearly and quarterly reports right on TradingView.
Harrow, Inc. is going to release the next earnings report on Mar 13, 2025. Keep track of upcoming events with our Earnings Calendar.
HROW earnings for the last quarter are −0.12 USD per share, whereas the estimation was −0.05 USD resulting in a −128.57% surprise. The estimated earnings for the next quarter are 0.13 USD per share. See more details about Harrow, Inc. earnings.
Harrow, Inc. revenue for the last quarter amounts to ‪49.26 M‬ USD, despite the estimated figure of ‪52.80 M‬ USD. In the next quarter, revenue is expected to reach ‪64.55 M‬ USD.
HROW net income for the last quarter is ‪−4.22 M‬ USD, while the quarter before that showed ‪−6.47 M‬ USD of net income which accounts for 34.81% change. Track more Harrow, Inc. financial stats to get the full picture.
No, HROW doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 21, 2024, the company has 315.00 employees. See our rating of the largest employees — is Harrow, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Harrow, Inc. EBITDA is ‪4.04 M‬ USD, and current EBITDA margin is 9.92%. See more stats in Harrow, Inc. financial statements.
Like other stocks, HROW shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Harrow, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Harrow, Inc. technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Harrow, Inc. stock shows the buy signal. See more of Harrow, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.